Abstract:Background: Diabetic nephropathy (DN) is a severe complication of diabetes mellitus (DM). Pancreas or islet transplantation has been reported to prevent the development of DN lesions and ameliorate or reverse existing glomerular lesions in animal models. Shortage of pancreas donor is a severe problem. Islets derived from stem cells may offer a potential solution to this problem. Objective: To evaluate the effect of stem cell-derived islet transplantation on DN in a rat model of streptozotocin-induced DM. Methods: Pancreatic progenitor cells were isolated from aborted fetuses of 8 weeks of gestation. And islets were prepared by suspension culture after a differentiation of progenitor cells in medium containing glucagon-like peptide-1 (Glp-1) and nicotinamide. Then islets were transplanted into the liver of diabetic rats via portal vein. Blood glucose, urinary volume, 24 h urinary protein and urinary albumin were measured once biweekly for 16 weeks. Graft survival was evaluated by monitoring human C-peptide level in rat sera and by immunohistochemical staining for human mitochondrial antigen and human C-peptide in liver tissue. The effect of progenitor-derived islets on filtration membrane was examined by electron microscopy and real-time polymerase chain reaction (PCR). Immunohistochemical staining, real-time PCR and western blot were employed for detecting fibronectin, protein kinase C beta (PKCβ), protein kinase A (PKA), inducible nitric oxide synthase (iNOS) and superoxide dismutase (SOD). Results: Islet-like clusters derived from 8th gestational-week human fetal pancreatic progenitors survived in rat liver. And elevated serum level of human C-peptide was detected. Blood glucose, 24 h urinary protein and urinary albumin were lower in progenitor cell group than those in DN or insulin treatment group. Glomerular basement membrane thickness and fibronectin accumulation decreased significantly while podocytes improved morphologically in progenitor cell group. Furthermore, receptor of advanced glycation end products and PKCβ became down-regulated whereas PKA up-regulated by progenitor cell-derived islets. And iNOS rose while SOD declined. Conclusions: DN may be reversed by transplantation of human fetal pancreatic progenitor cell-derived islets. And fetal pancreatic progenitor cells offer potential resources for cell replacement therapy.

Improvement effects of transplanting pancreatic islet that previously incubated with biomaterials on the diabetic nephropathy in STZ- diabetic rats

In Vitro and In Vivo Improvement of Islet Quality and Transplantation Successes following Islet Treatment with Biomaterials in Diabetic Rats

Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model

Transplantation of human fetal pancreatic progenitor cells ameliorates renal injury in streptozotocin-induced diabetic nephropathy

Islet transplantation alleviates podocyte injury in diabetic nephropathy rats

3D printed VEGF-CPO biomaterial scaffold to promote subcutaneous vascularization and survival of transplanted islets for the treatment of diabetes

Stndy on Diabetic Rat Therapy by Islet Transplantation with Rat Mesenchymal Stem Cells and Scaffold of Pig Small Intestinal Submucosal

The Revascular and Transplanted Effects of Vascular Endothelial Cells on Islets Grafts

The Influences of Islet Transplantation on Metabolic Abnormalities and Diabetic Complications.

Islet transplantation promotes podocyte regeneration in a model of diabetic nephropathy

Islet graft survival and function: concomitant culture and transplantation with vascular endothelial cells in diabetic rats.

Biomaterial-assisted strategies to improve islet graft revascularization and transplant outcomes

Improvement of Massive Human Islet Isolation Techniques and the Evaluation of Isolated Human Islets

Pancreatic islet transplantation: current advances and challenges

Advances in the protection of islet grafts function

Recent Advances in Islet Transplantation for Diabetes

Combined Microencapsulated Islet Transplantation and Revascularization of Aortorenal Bypass in a Diabetic Nephropathy Rat Model

Insulin Therapy Improves Islet Functions by Restoring Pancreatic Vasculature in High-Fat Diet-Fed Streptozotocin-Diabetic Rats

The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions

Effects of pre-vascularization of tissue-engineered constructs on the survival of transplanted pancreaticislets